APP and Down syndrome: This is supported by the observations that only a portion of patients with histopathologically defined moderate-to-severe CAA develop hemorrhagic alterations [103], and that an increased risk for ICH development in adult patients with Down syndrome (with the trisomy of chromosome 21 resulting in an excess copy of the amyloid precursor protein (APP) and subsequent severe CAA) is not established [107].